Consolidated Condensed Statements of Operations (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Jul. 28, 2013	Jul. 29, 2012	Jul. 28, 2013	Jul. 29, 2012
Income Statement [Abstract]
Net sales	$ 1,975	$ 2,343	$ 5,521	$ 7,073
Cost of products sold	1,169	1,413	3,325	4,347
Gross margin	806	930	2,196	2,726
Operating expenses:
Research, development and engineering	334	309	982	933
Marketing and selling	111	118	334	374
General and administrative	97	137	348	465
Impairment of goodwill and intangible assets (Note 8)	0	0	278	0
Restructuring charges and asset impairments (Note 10)	14	44	33	44
Total operating expenses	556	608	1,975	1,816
Income from operations	250	322	221	910
Impairments of strategic investments (Notes 3 and 4)	3	0	5	3
Interest and other expenses (Note 9)	23	24	71	72
Interest and other income, net	4	4	11	13
Income before income taxes	228	302	156	848
Provision for income taxes	60	84	83	224
Net income	$ 168	$ 218	$ 73	$ 624
Earnings per share:
Basic (in dollars per share)	$ 0.14	$ 0.17	$ 0.06	$ 0.49
Diluted (in dollars per share)	$ 0.14	$ 0.17	$ 0.06	$ 0.48
Weighted average number of shares:
Basic (in shares)	1,203	1,257	1,201	1,282
Diluted (in shares)	1,220	1,268	1,218	1,292